0001179110-18-001372.txt : 20180201
0001179110-18-001372.hdr.sgml : 20180201
20180201174703
ACCESSION NUMBER: 0001179110-18-001372
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180130
FILED AS OF DATE: 20180201
DATE AS OF CHANGE: 20180201
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ford Robert B
CENTRAL INDEX KEY: 0001612571
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-02189
FILM NUMBER: 18567913
MAIL ADDRESS:
STREET 1: 100 ABBOTT PARK ROAD
STREET 2: AP6A-2, D-032L
CITY: ABBOTT PARK
STATE: IL
ZIP: 60064-6092
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ABBOTT LABORATORIES
CENTRAL INDEX KEY: 0000001800
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 360698440
STATE OF INCORPORATION: IL
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 ABBOTT PARK ROAD
STREET 2: D-322 AP6D
CITY: ABBOTT PARK
STATE: IL
ZIP: 60064-3500
BUSINESS PHONE: 8479376100
MAIL ADDRESS:
STREET 1: 100 ABBOTT PARK ROAD
STREET 2: D-322 AP6D
CITY: ABBOTT PARK
STATE: IL
ZIP: 60064-3500
4
1
edgar.xml
FORM 4 -
X0306
4
2018-01-30
0
0000001800
ABBOTT LABORATORIES
ABT
0001612571
Ford Robert B
100 ABBOTT PARK ROAD
ABBOTT PARK
IL
60064-6400
0
1
0
0
Executive Vice President
Common shares without par value
2018-01-30
4
M
0
4467
26.1879
A
56633
D
Common shares without par value
2018-01-30
4
M
0
10400
22.3919
A
67033
D
Common shares without par value
2018-01-30
4
M
0
19600
27.0336
A
86633
D
Common shares without par value
2018-01-30
4
M
0
49000
34.94
A
135633
D
Common shares without par value
2018-01-30
4
S
0
200
62.81
D
135433
D
Common shares without par value
2018-01-30
4
S
0
300
62.82
D
135133
D
Common shares without par value
2018-01-30
4
S
0
100
62.825
D
135033
D
Common shares without par value
2018-01-30
4
S
0
527
62.83
D
134506
D
Common shares without par value
2018-01-30
4
S
0
100
62.84
D
134406
D
Common shares without par value
2018-01-30
4
S
0
200
62.845
D
134206
D
Common shares without par value
2018-01-30
4
S
0
100
62.85
D
134106
D
Common shares without par value
2018-01-30
4
S
0
100
62.86
D
134006
D
Common shares without par value
2018-01-30
4
S
0
400
62.88
D
133606
D
Common shares without par value
2018-01-30
4
S
0
200
62.89
D
133406
D
Common shares without par value
2018-01-30
4
S
0
200
62.8975
D
133206
D
Common shares without par value
2018-01-30
4
S
0
100
62.90
D
133106
D
Common shares without par value
2018-01-30
4
S
0
200
62.91
D
132906
D
Common shares without par value
2018-01-30
4
S
0
200
62.93
D
132706
D
Common shares without par value
2018-01-30
4
S
0
1100
62.95
D
131606
D
Common shares without par value
2018-01-30
4
S
0
200
62.955
D
131406
D
Common shares without par value
2018-01-30
4
S
0
2700
62.96
D
128706
D
Common shares without par value
2018-01-30
4
S
0
200
62.965
D
128506
D
Common shares without par value
2018-01-30
4
S
0
2000
62.97
D
126506
D
Common shares without par value
2018-01-30
4
S
0
400
62.975
D
126106
D
Common shares without par value
2018-01-30
4
S
0
1000
62.98
D
125106
D
Common shares without par value
2018-01-30
4
S
0
1346
62.985
D
123760
D
Common shares without par value
2018-01-30
4
S
0
100
62.9875
D
123660
D
Common shares without par value
2018-01-30
4
S
0
3600
62.99
D
120060
D
Common shares without par value
2018-01-30
4
S
0
5303
62.995
D
114757
D
Common shares without par value
2018-01-30
4
S
0
21789
63
D
92968
D
Option (right to buy)
26.1879
2018-01-30
4
M
0
4467
0
D
2013-02-19
2020-02-18
Common shares
4467
0
D
Option (right to buy)
22.3919
2018-01-30
4
M
0
10400
0
D
2014-02-18
2021-02-17
Common shares
10400
0
D
Option (right to buy)
27.0336
2018-01-30
4
M
0
19600
0
D
2015-02-17
2022-02-16
Common shares
19600
0
D
Option (right to buy)
34.94
2018-01-30
4
M
0
49000
0
D
2016-02-15
2023-02-14
Common shares
49000
0
D
Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.
These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).Form 1 of 2.
John A. Berry, by power of attorney for Robert B. Ford
2018-02-01